Get started
CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKDCHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKDCHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD

CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪355.15 M‬ HKD
Fund flows (1Y)
‪−202.96 M‬ HKD
Dividend yield (indicated)
0.66%
Discount/Premium to NAV
−1.8%
Shares outstanding
‪38.80 M‬
Expense ratio
0.71%

About CHINA ASSET MANAGEMENT (HK) CHINAAMC HANG SENG BIOTECH ETF HKD


Issuer
CITIC Securities Co., Ltd.
Brand
ChinaAMC
Home page
chinaamc.com.hk
Inception date
Mar 18, 2021
Index tracked
Hang Seng Biotech Index - HKD - Benchmark TR Net
Replication method
Physical
Management style
Passive
Primary advisor
China Asset Management (Hong Kong) Ltd.
ISIN
HK0000711199
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
Hong Kong
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of January 22, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.82%
Health Technology86.03%
Consumer Non-Durables4.07%
Retail Trade2.65%
Distribution Services2.19%
Technology Services1.91%
Health Services1.67%
Commercial Services1.31%
Bonds, Cash & Other0.18%
Cash0.18%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows